ThreeForMe™ Laser Treatments
Say goodbye to tired and dull skin
Icon’s unique ThreeForMe™ Laser Treatment addresses the most common skin concerns, including wrinkles, sun damage, and facial veins all in one treatment. Achieved using Cynosure’s Icon® technology, the ThreeForMe treatment has been optimized to provide the best results on all three skin conditions with two steps in just 30-minute sessions.
About The Treatment:
Step 1 – For sun damage and facial veins
A combination of Intense Pulsed Light (IPL) and 1540 laser treatment uses very fast pulses of light to treat discoloration and facial vessels. This will help to treat sun damage including freckles, brown spots or age spots, and unsightly veins including broken blood vessels, facial veins, and rosacea.
Step 2 – For fine lines and wrinkles
‘Microbeam’ laser technology stimulates collagen and elastin production with heat, naturally tightening and lifting the skin to smooth out lines and wrinkles and reduce the appearance of scars.
Immediately after ThreeForMe™ Laser Treatment, you may feel a mild sunburn-like sensation. Minor swelling may last for 24 hours and redness may be visible for up to three days. During this time, you may experience some flaking that will reveal glowing skin underneath and the continued reduction of fine lines and wrinkles as your body produces new collagen. After the redness has subsided, you may return to your regular makeup and skincare routine.
One to three treatment sessions may be necessary to achieve your desired results and continued improvements will appear over the next six months.
- Veins and Vascular Lesions
- Facial blood vessels (spider veins)
- Fine lines and wrinkles
- Sun Damage and Freckles
- Redness and Brown Spots
- Acne and Scarring
Find out if Three for Me is right for you!
Call us at 412-683-3358 or complete the following form.
Schedule A Consultation
Fill out the form below to request your consultation and we will call you back to schedule your appointment. For more information, please visit our Appointment & Consultation Policy page.